Key Points Johnson & Johnson (NYSE: JNJ) just rewarded its shareholders again with a quarterly dividend. As a Dividend King, ...

Market analysts liked the news, with analysts for Cantor writing that this was a “best-case data update.” ...

Johnson & Johnson (NYSE:JNJ) shares traded in the green on Monday, snapping six consecutive days of losses. The stock closed ...

Johnson & Johnson closed $19.62 below its 52-week high ($168.85), which the company achieved on September 4th.

Johnson & Johnson’s high EBIT Margin [TTM] of 26.40% is not only an indicator of the company’s financial health, but also demonstrates its positioning within the Pharmaceuticals Industry.

Johnson & Johnson has increased its dividend for more than 60 consecutive years. And thanks to $19 billion in annual free ...

Johnson & Johnson must adapt and evolve our businesses in the midst of a complex and rapidly changing external environment,” a company spokesperson said in an emailed statement. The company ...

As a result, Icontinue to cover Johnson & Johnson with a 'Buy' rating. Equally important, the New Brunswick, New Jersey-based company, led by its CEO Joaquin Duato, was able to make significant ...

Heating, ventilation, air conditioning (HVAC), and building controls company Johnson Controls (NYSE: JCI) rose by 11% in ...